Particle.news
Download on the App Store

Doctors Outline Safe Use of Peptides as FDA Weighs Easing Restrictions

Experts warn many popular peptides lack solid trials, with sourcing risks from online sellers.

Overview

  • The FDA is weighing looser compounding rules for select experimental peptides, including BPC‑157, which are often promoted for healing and recovery.
  • Peptides are short amino‑acid chains that signal body functions, with approved examples like insulin and GLP‑1 drugs used for diabetes and weight loss.
  • Physicians urge prescriptions, baseline lab checks, and sourcing from 503A or 503B pharmacies because online sellers often lack quality controls.
  • Doctors warn against stacking or mixing peptides because interactions and proper dosing are not well defined.
  • Out‑of‑pocket costs often run from a few hundred to thousands of dollars per month, while many wellness claims still lack randomized human trials.